Atlas Trials

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

Clinical trial NCT00753467 · UNKNOWN

Trial details

NCT number
NCT00753467
Sponsor
Huntington Medical Research Institutes
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B
Start date
2008-09-01
Primary completion
2009-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.